2025 Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis Group Chronic Malignancies Working Party (CMWP) 1st listed author Juan Carlos Hernández-Boluda Journal Blood.
2025 Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT Group Chronic Malignancies Working Party (CMWP) Practice Harmonisation and Guidelines Committee 1st listed author Nicola Polverelli Journal Blood.
2025 Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT Group Chronic Malignancies Working Party (CMWP) Other society 1st listed author Carmelo Gurnari Journal Blood.
2025 Integrating palliative care into hematopoietic cell transplantation and cellular therapy training Group Trainee Committee 1st listed author Esra Gulderen Journal Bone Marrow Transplant.
2025 Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee Group Lymphoma Working Party (LWP) Practice Harmonisation and Guidelines Committee 1st listed author Gandhi Damaj Journal Lancet Haematol.
2025 Changing scenario in prevention and management of CMV infections in pediatric hematopoietic stem cell transplant patients Group Infectious Diseases Working Party (IDWP) 1st listed author Federica Galaverna Journal Bone Marrow Transplant.
2025 Ask, do not tell: consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe Group Patient Advocacy Committee Other society 1st listed author Hélène Schoemans Journal Lancet Haematol.
2025 Definition of relapse criteria in patients with rapidly progressive systemic sclerosis treated with autologous haemopoietic stem cell transplantation Group Autoimmune Diseases Working Party (ADWP) 1st listed author Nicoletta Del Papa Journal Bone Marrow Transplant.
2025 A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm Group Chronic Malignancies Working Party (CMWP) 1st listed author Alexandros Rampotas Journal Bone Marrow Transplant.
2025 Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT Group Transplant Complications Working Party (TCWP) 1st listed author Ivan Moiseev Journal Bone Marrow Transplant.
2025 Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party Group Transplant Complications Working Party (TCWP) 1st listed author Agnieszka Tomaszewska Journal Cancers (Basel).
2025 Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition Group Cellular Therapy & Immunobiology Working Party (CTIWP) GoCART Coalition Other society 1st listed author Ganesh Ramesh Journal Bone Marrow Transplant.